Medicare Enrolled

Dr. Sobia Nabeel, M.D

Hematology & Oncology · Arlington, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
801 W INTERSTATE 20 STE 132, Arlington, TX 76017
6822748181
In practice since 2009 (17 years)
NPI: 1306088950 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nabeel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nabeel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nabeel

Dr. Sobia Nabeel is a hematology & oncology in Arlington, TX, with 17 years in practice. Based on federal Medicare data, Dr. Nabeel performed 2,469 Medicare services across 1,008 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nabeel received a total of $2,825 from 32 pharmaceutical and/or device companies across 97 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nabeel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 42% volume in TX$ $2,825 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,469
Medicare services
Top 42% in TX for hematology & oncology
1,008
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~145 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Dexamethasone injection (steroid)452$0$7
Blood draw (venipuncture)319$8$10
Complete blood count (CBC) with differential290$8$22
Comprehensive metabolic blood panel225$10$29
Office visit, established patient (30-39 min)166$95$219
Leuprolide acetate (for depot suspension), 7.5 mg143$127$1,043
Administration of chemotherapy into vein, 1 hour or less91$102$325
Office visit, established patient, complex (40-54 min)78$135$295
Drug injection, under skin or into muscle65$10$54
PSA test (prostate cancer screening)58$18$51
Testosterone (hormone) level, total51$25$71
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less51$22$80
New patient office visit, complex (60-74 min)51$146$420
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle50$25$86
Office visit, established patient (20-29 min)40$66$150
Ferritin level test (iron stores)39$13$38
Iron level test37$6$18
Iron binding capacity test37$9$24
Vitamin D level test36$29$75
Thyroid stimulating hormone (TSH) test32$16$48
Injection of additional new drug or substance into vein30$12$51
Vitamin B-12 level test23$15$42
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less21$48$145
Lactate dehydrogenase (enzyme) level20$6$17
C-reactive protein test (inflammation marker)15$5$15
Red blood count, manual test13$4$12
Sed rate test (inflammation marker)13$3$8
Folic acid level test12$14$41
Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies11$24$68
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.9% high complexity
27.9% medium
69.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,825
Total received (2018-2024)
Avg $404/year across 7 years
Bottom 47% in TX for hematology & oncology
32
Companies
97
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,249 (79.6%)
Other
Charitable contributions, space rental, and other categories
$377 (13.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$199 (7.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$116
2023
$691
2022
$1,003
2021
$829
2020
$21
2019
$53
2018
$113

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$767
PFIZER INC.
$219
Novartis Pharmaceuticals Corporation
$210
Lilly USA, LLC
$192
Astellas Pharma US Inc
$182
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Merck Sharp & Dohme Corporation
$103
Amgen Inc.
$94
Gilead Sciences, Inc.
$82
E.R. Squibb & Sons, L.L.C.
$75
GENZYME CORPORATION
$65
TerSera Therapeutics LLC
$53
Rigel Pharmaceuticals, Inc.
$52
AstraZeneca Pharmaceuticals LP
$51
Eisai Inc.
$48
EISAI INC.
$47
Celgene Corporation
$40
PUMA BIOTECHNOLOGY, INC.
$39
Incyte Corporation
$39
Sobi, Inc
$33
Genentech USA, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$26
Octapharma USA, Inc.
$26
Kite Pharma, Inc.
$25
MorphoSys, US Inc.
$24
Dendreon Pharmaceuticals LLC
$21
GlaxoSmithKline, LLC.
$20
Seagen Inc.
$19
Myovant Sciences Inc.
$19
Ipsen Biopharmaceuticals, Inc
$19
ARRAY BIOPHARMA INC
$18
ABBVIE INC.
$17
Top 3 companies account for 42.3% of total payments
Associated products mentioned in payments ›
ABECMA · BOSULIF · BRAFTOVI · DOPTELET · ELITEK · ERLEADA · Halaven · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUPRON DEPOT · LYNPARZA · Lenvima · MONJUVI · NERLYNX · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · ORGOVYX · PADCEV · PROVENGE · Perjeta · Prolia · REBLOZYL · RYBREVANT · Revlimid · SOMATULINE DEPOT · TUKYSA · Tavalisse · Trodelvy · VERZENIO · XALKORI · XTANDI · ZEJULA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $114 per 100 Medicare services performed
Looking for a hematology & oncology in Arlington?
Compare hematology & oncologys in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
117
Per 100K population
5.5
County median income
$81,905
Nearest hospital
USMD HOSPITAL AT ARLINGTON L P
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nabeel is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nabeel experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Nabeel performed 452 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nabeel receive payments from pharmaceutical companies?
Yes. Dr. Nabeel received a total of $2,825 from 32 companies across 97 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nabeel's costs compare to other hematology & oncologys in Arlington?
Dr. Nabeel's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nabeel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →